approval · primary record
RIPRETINIB
FDA · NDA · 2025-05-06
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-05-06 |
| Brand | QINLOCK |
| Sponsor | DECIPHERA PHARMS |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:53.684Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:RIPRETINIB:2025-05-06
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.